Vifor Pharma AG logo

Vifor Pharma AG - Registered Shares

LTS:0RPD (Switzerland)   Registered Shares
(Delisted) CHF 165.55 (0%) Dec 23
78.66
P/B:
3.29
Market Cap:
CHF 10.78B ($ 11.91B)
Enterprise V:
CHF 10.38B ($ 11.47B)
Volume:
-
Avg Vol (2M):
72.00

Business Description

Description
Vifor Pharma AG is a specialty drug manufacturing and licensing company. It researches, develops, and produces its pharmaceutical products and markets and distributes them worldwide. Most of its sales are generated in the USA, with Europe also a strong contributor. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
Name Current Vs Industry Vs History
Cash-To-Debt 1.69
Equity-to-Asset 0.68
Debt-to-Equity 0.17
Debt-to-EBITDA 0.91
Interest Coverage 39.56
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 7.89
Distress
Grey
Safe
Beneish M-Score -3.04
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
6-1 Month Momentum % -1.48
12-1 Month Momentum % 4.78

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.91
Quick Ratio 1.56
Cash Ratio 1.01
Days Inventory 198.26
Days Sales Outstanding 87.24
Days Payable 81.91

Dividend & Buy Back

Name Current Vs Industry Vs History
Dividend Yield % 1.21
Dividend Payout Ratio 0.89
Forward Dividend Yield % 1.21
5-Year Yield-on-Cost % 1.21
Shareholder Yield % 1.48

Financials

LTS:0RPD's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Vifor Pharma AG Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil CHF) 1,824.6
EPS (TTM) (CHF) 2.22
Beta 0
Volatility % 58.06
14-Day RSI 0
14-Day ATR (CHF) 1.859282
20-Day SMA (CHF) 0
12-1 Month Momentum % 4.78
52-Week Range (CHF) 157.9 - 196.79506
Shares Outstanding (Mil) 64.89

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Vifor Pharma AG Filings

Filing Date Document Date Form
No Filing Data

Vifor Pharma AG Stock Events

Financials Calendars
Event Date Price(CHF)
No Event Data

Vifor Pharma AG Frequently Asked Questions

What is Vifor Pharma AG(LTS:0RPD)'s stock price today?
The current price of LTS:0RPD is CHF165.55. The 52 week high of LTS:0RPD is CHF196.80 and 52 week low is CHF157.90.
When is next earnings date of Vifor Pharma AG(LTS:0RPD)?
The next earnings date of Vifor Pharma AG(LTS:0RPD) is .
Does Vifor Pharma AG(LTS:0RPD) pay dividends? If so, how much?
The  Dividend Yield %  of Vifor Pharma AG(LTS:0RPD) is 1.21% (As of Today), Highest Dividend Payout Ratio of Vifor Pharma AG(LTS:0RPD) was 3.84. The lowest was 0.78. And the median was 0.93. The  Forward Dividend Yield % of Vifor Pharma AG(LTS:0RPD) is 1.21%. For more information regarding to dividend, please check our Dividend Page.

Press Release

Subject Date
No Press Release